肖泓教授基于扶阳理论治疗肺间质纤维化的临床经验举隅

Professor Xiao Hong’s Clinical Experience in Treating Pulmonary Interstitial Fibrosis Based on Fuyang Theory

摘要: 肺间质纤维化(pulmonary interstitial fibrosis, PIF)是一种慢性、进行性、纤维化性疾病，其中位生存期短，预后差。西医治疗主要使用糖皮质激素、免疫抑制剂、抗纤维化药物，其治疗效果欠佳且不良反应明显，价格昂贵。随着中医中药的发展，大量研究表明，中医在治疗PIF方面具有独特优势，在提升患者生活品质、减慢患者疾病进展速度方面取得明显效果。文章总结了肖泓教授对肺间质纤维化的认识及临床经验。

Abstract: Pulmonary interstitial fibrosis (PIF) is a chronic, progressive, fibrotic disease characterized by short median survival and poor prognosis. Western medical treatments primarily involve glucocorticoids, immunosuppressants, and antifibrotic agents, which exhibit suboptimal therapeutic efficacy, significant adverse effects, and high costs. With the advancement of traditional Chinese medicine (TCM), numerous studies have demonstrated that TCM possesses unique advantages in treating PIF, achieving notable improvements in patients’ quality of life and slowing disease progression. This article summarizes Professor Xiao Hong’s understanding and clinical experience in managing pulmonary interstitial fibrosis.